American Financial Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

American Financial Group’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,774	Closed	-$30K	–	120
2020 Q2	$30K	Hold	10,774	–	–	﹤0.01%	122
2020 Q1	$26K	Hold	10,774	–	–	﹤0.01%	134
2019 Q4	$55K	Hold	10,774	–	–	﹤0.01%	128
2019 Q3	$70K	Hold	10,774	–	–	0.01%	136
2019 Q2	$67K	Sell	10,774 -1	-0%	-$8	0.01%	139
2019 Q1	$115K	Hold	10,775	–	–	0.01%	130
2018 Q4	$86K	Hold	10,775	–	–	0.01%	134
2018 Q3	$209K	Hold	10,775	–	–	0.02%	104
2018 Q2	$195K	Hold	10,775	–	–	0.02%	106
2018 Q1	$115K	Hold	10,775	–	–	0.01%	108
2017 Q4	$454K	Sell	10,775 -10,774	-50%	-$483K	0.05%	92
2017 Q3	$1.19M	Hold	21,549	–	–	0.12%	83
2017 Q2	$4M	Hold	21,549	–	–	0.38%	65
2017 Q1	$2.58M	Hold	21,549	–	–	0.24%	76
2016 Q4	$2.14M	Hold	21,549	–	–	0.21%	80
2016 Q3	$2.41M	Hold	21,549	–	–	0.17%	81
2016 Q2	$2.21M	Hold	21,549	–	–	0.17%	83
2016 Q1	$1.98M	Hold	21,549	–	–	0.15%	86
2015 Q4	$3.11M	Buy	+21,549	New	+$2.8M	0.24%	77

Other funds holding SIOX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

American Financial Group's SIOX Position: Q3 2020 in Review

American Financial Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2020, closing a stake of 10,774 shares — an estimated $30K sold.

American Financial Group first reported a position in SIOX in Q4 2015 and held it in 19 quarters. The position peaked at $4M in Q2 2017. 50 funds tracked by Wall St. Rank hold SIOX as of Q3 2020.

American Financial Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
American Financial Group sold 10,774 Sio Gene Therapies Inc. Common Stock shares in Q3 2020, an estimated $30K.
American Financial Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 19 quarters.
American Financial Group's Sio Gene Therapies Inc. Common Stock position peaked at $4M in Q2 2017.
50 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2020.

Based on American Financial Group's 13F filing for Q3 2020, filed 9 Nov 2020.